Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 17;12(2):233.
doi: 10.3390/healthcare12020233.

Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes

Diego Primavera  1 , Mauro Giovanni Carta  1 , Ferdinando Romano  2 , Federica Sancassiani  1 , Elisabetta Chessa  1   3 , Alberto Floris  1   3 , Giulia Cossu  1 , Antonio Egidio Nardi  4 , Matteo Piga  1   3 , Alberto Cauli  1   3
Affiliations

Quality of Life in Systemic Lupus Erythematosus and Other Chronic Diseases: Highlighting the Amplified Impact of Depressive Episodes

Diego Primavera et al. Healthcare (Basel). .

Abstract

Background: Extensive research has explored SLE's impact on health-related quality of life (H-QoL), especially its connection with mental wellbeing. Recent evidence indicates that depressive syndromes significantly affect H-QoL in SLE. This study aims to quantify SLE's impact on H-QoL, accounting for comorbid depressive episodes through case-control studies.

Methods: A case-control study was conducted with SLE patients (meeting the ACR/EULAR 2019 criteria of age ≥ 18). The control group was chosen from a community database. H-QoL was measured with the SF-12 questionnaire, and PHQ-9 was used to assess depressive episodes.

Results: SLE significantly worsened H-QoL with an attributable burden of 5.37 ± 4.46. When compared to other chronic diseases, only multiple sclerosis had a worse impact on H-QoL. Major depressive episodes had a significant impact on SLE patients' H-QoL, with an attributable burden of 9.43 ± 5.10, similar to its impact on solid cancers but greater than its impact on other diseases.

Conclusions: SLE has a comparable impact on QoL to serious chronic disorders. Concomitant depressive episodes notably worsened SLE patients' QoL, exceeding other conditions, similar to solid tumors. This underscores the significance of addressing mood disorders in SLE patients. Given the influence of mood disorders on SLE outcomes, early identification and treatment are crucial.

Keywords: SLE; depression; quality of life.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Gergianaki I., Fanouriakis A., Repa A., Tzanakakis M., Adamichou C., Pompieri A., Spirou G., Bertsias A., Kabouraki E., Tzanakis I., et al. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: Data from the community-based lupus registry of Crete, Greece. Ann. Rheum. Dis. 2017;76:1992–2000. doi: 10.1136/annrheumdis-2017-211206. - DOI - PubMed
    1. Song L., Wang Y., Zhang J., Song N., Xu X., Lu Y. The risks of cancer development in systemic lupus erythematosus (SLE) patients: A systematic review and meta-analysis. Arthritis Res. Ther. 2018;20:270. doi: 10.1186/s13075-018-1760-3. - DOI - PMC - PubMed
    1. Barber M.R.W., Drenkard C., Falasinnu T., Hoi A., Mak A., Kow N.Y., Svenungsson E., Peterson J., Clarke A.E., Ramsey-Goldman R. Global epidemiology of systemic lupus erythematosus. Nat. Rev. Rheumatol. 2021;17:515–532. doi: 10.1038/s41584-021-00668-1. - DOI - PMC - PubMed
    1. Yu H., Nagafuchi Y., Fujio K. Clinical and Immunological Biomarkers for Systemic Lupus Erythematosus. Biomolecules. 2021;11:928. doi: 10.3390/biom11070928. - DOI - PMC - PubMed
    1. Fan Y., Hao Y.J., Zhang Z.L. Systemic lupus erythematosus: Year in review 2019. Chin. Med. J. 2020;133:2189–2196. doi: 10.1097/CM9.0000000000000983. - DOI - PMC - PubMed

LinkOut - more resources